|
⚲
|
| Keyboard |
| Mendlein John
✚
|
|
|---|---|
| CIK # | 0001238362 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001238362] | |
| 4 | [0001238362] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Mendlein John | |
| Fate Therapeutics Inc | |
| Omega Therapeutics Inc | |
| aTYR Pharma Inc | |
| Moderna Inc | |
| Editas Medicine Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2025-05-29 | Grant | 55,000 | $0.00 | |
|
Omega Therapeutics Inc OMGA
Stock Option (Right to Buy) · derivative
|
2024-06-20 | Grant | 25,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2024-06-07 | Grant | 40,000 | $0.00 | |
|
Omega Therapeutics Inc OMGA
Stock Option (Right to Buy) · derivative
|
2023-06-07 | Grant | 18,118 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2023-06-06 | Grant | 40,000 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-01-19 | Option exercise | 28,461 | $1.37 | 38,992 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2023-01-19 | Option exercise | 28,461 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-01-13 | Buy | 36,631 | $5.43 | 198,906 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2023-01-11 | Buy | 88,048 | $5.67 | 499,232 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-06-09 | Grant | 11,893 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-06-09 | Grant | 8,650 | $0.00 | |
|
Omega Therapeutics Inc OMGA
Option (Right to Buy) · derivative
|
2022-06-08 | Grant | 18,118 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-06-03 | Sell | 1,364 | $22.79 | 31,086 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-03-10 | Option exercise | 31,562 | $1.63 | 51,446 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-03-10 | Sell | 12,069 | $35.48 | 428,208 |
|
Fate Therapeutics Inc FATE
Common Stock
|
2022-03-10 | Sell | 19,493 | $34.73 | 676,992 |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2022-03-10 | Option exercise | 31,562 | $0.00 | |
|
Fate Therapeutics Inc FATE
Common Stock
|
2021-06-02 | Grant | 2,681 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (Right to Buy) · derivative
|
2021-06-02 | Grant | 4,334 | $0.00 | |
|
Fate Therapeutics Inc FATE
Stock Option (right to buy) · derivative
|
2020-05-01 | Grant | 16,000 | ||
| showing 20 of 51 most recent transactions | |||||